Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Studyopen accessVaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
- Other Titles
- Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
- Authors
- Kim, Yoo-Yeon; Choe, Young June; Kim, Jia; Kim, Ryu Kyung; Jang, Eun Jung; Lee, Hyeryeon; Yi, Seonju; Lee, Sangwon; Park, Young-Joon
- Issue Date
- Mar-2023
- Publisher
- 대한의학회
- Keywords
- Coronavirus; COVID-19; SARS-CoV-2; Vaccine; Booster
- Citation
- Journal of Korean Medical Science, v.38, no.11, pp 1 - 6
- Pages
- 6
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- Journal of Korean Medical Science
- Volume
- 38
- Number
- 11
- Start Page
- 1
- End Page
- 6
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/62927
- DOI
- 10.3346/jkms.2023.38.e87
- ISSN
- 1011-8934
1598-6357
- Abstract
- National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05-0.08). The risk of death was reduced during the omicron period compared to the delta period (aOR, 0.75; 95% confidence interval, 0.67-0.84).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Pediatrics > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.